Results 181 to 190 of about 15,402 (239)

Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study. [PDF]

Hemasphere
Rögnvaldsson S, Óskarsson JÞ, Thorsteinsdóttir S, Hultcrantz M, Palmason R, Sverrisdottir IS, Eythorsson E, Long TE, Olafsson I, Thorsteinsdottir I, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Jonsson A, Durie BGM, Harding S, Landgren O, Love TJ, Kristinsson SY.   +19 more
europepmc   +1 more source

Bortezomib in the Treatment of Acquired von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance [PDF]

, 2014
Byrd, Kenneth, Truong, Phu
core   +2 more sources

Monoclonal Gammopathy of Undetermined Significance Diagnosed by Persistent Anemia Following Living Kidney Transplantation: A Case Report. [PDF]

Cureus
Tomizawa M, Hori S, Inoue K, Yoneda T, Fujimoto K.   +4 more
europepmc   +1 more source

COVID-19-Associated Cold Agglutinin Syndrome and Hemophagocytosis in a Patient with Monoclonal Gammopathy of Undetermined Significance. [PDF]

Mediterr J Hematol Infect Dis
Yu Y, Yang K.
europepmc   +1 more source

Skeletal health in the precursor stages of multiple myeloma: fracture risk and bone phenotypes in monoclonal gammopathy of undetermined significance and smouldering myeloma

Melissa D. Cantley, Laura J. Trainor, Emma A-J. Cheney, Suzanne M. Watt, Kate Vandyke   +4 more
openalex   +1 more source

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification. [PDF]

Blood Cancer J
Gor R, Shivakumar J, Surana P, Wei J, Murakhovskaya I, Goldfinger M, Kornblum N, Shapiro L, Shastri A, Gupta R, Levitz D, Konopleva M, Feldman E, Gritsman K, Sica RA, Mantzaris I, Verma A, Cooper D, Janakiram M, Shah N.   +19 more
europepmc   +1 more source

Approaching hypercalcemia in monoclonal gammopathy of undetermined significance: insights from the iStopMM screening study. [PDF]

Blood
Jónsdóttir ÁH, Sigurjónsdóttir HÁ, Thorsteinsdóttir S, Long TE, Sverrisdóttir IS, Eythorsson E, Óskarsson JÞ, Palsson R, Indridason OS, Viðarsson B, Onundarson PT, Ólafsson Í, Þorsteindóttir I, Agnarsson BA, Sigurðardóttir M, Jónsson Á, Hultcrantz M, Durie BGM, Harding S, Landgren O, Love TJ, Kristinsson SY, Rögnvaldsson S.   +22 more
europepmc   +1 more source

Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma [PDF]

, 2012

core   +1 more source

Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis. [PDF]

Blood Cancer J
Maeng CV, Rögnvaldsson S, Einarsson Long T, Brieghel C, Hermansen E, Niemann CU, Grønbæk K, Kristinsson SY, Thorsteinsdóttir S.   +8 more
europepmc   +1 more source

Mortality in the US Populations With Monoclonal Gammopathy of Undetermined Significance.

JAMA Oncol, 2023
Ji M, Huber JH, Schoen MW, Sanfilippo KM, Colditz GA, Wang SY, Chang SH.   +6 more
europepmc   +1 more source